<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Skeletal muscle is strongly dependent on oxidative phosphorylation for energy production </plain></SENT>
<SENT sid="1" pm="."><plain>Because the <z:hpo ids='HP_0000855'>insulin resistance</z:hpo> of skeletal muscle in type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> and <z:hpo ids='HP_0001513'>obesity</z:hpo> entails dysregulation of the oxidation of both carbohydrate and <z:chebi fb="23" ids="18059">lipid</z:chebi> fuels, the current study was undertaken to examine the potential contribution of perturbation of <z:hpo ids='HP_0001427'>mitochondrial</z:hpo> function </plain></SENT>
<SENT sid="2" pm="."><plain>Vastus lateralis muscle was obtained by percutaneous biopsy during fasting conditions from lean (n = 10) and <z:mp ids='MP_0001261'>obese</z:mp> (n = 10) nondiabetic volunteers and from volunteers with type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> (n = 10) </plain></SENT>
<SENT sid="3" pm="."><plain>The activity of <z:chebi fb="0" ids="28201">rotenone</z:chebi>-sensitive <z:chebi fb="0" ids="16908">NADH</z:chebi>:<z:chebi fb="0" ids="15379">O(2)</z:chebi> oxidoreductase, reflecting the overall activity of the respiratory chain, was measured in a <z:hpo ids='HP_0001427'>mitochondrial</z:hpo> fraction by a novel method based on providing access for <z:chebi fb="0" ids="16908">NADH</z:chebi> to intact mitochondria via alamethicin, a channel-forming antibiotic </plain></SENT>
<SENT sid="4" pm="."><plain><z:chebi fb="2" ids="16919">Creatine</z:chebi> kinase and <z:chebi fb="2" ids="50744">citrate</z:chebi> synthase activities were measured as markers of myocyte and mitochondria content, respectively </plain></SENT>
<SENT sid="5" pm="."><plain>Activity of <z:chebi fb="0" ids="28201">rotenone</z:chebi>-sensitive <z:chebi fb="0" ids="16908">NADH</z:chebi>:<z:chebi fb="0" ids="15379">O(2)</z:chebi> oxidoreductase was normalized to <z:chebi fb="2" ids="16919">creatine</z:chebi> kinase activity, as was <z:chebi fb="2" ids="50744">citrate</z:chebi> synthase activity </plain></SENT>
<SENT sid="6" pm="."><plain><z:chebi fb="0" ids="16908">NADH</z:chebi>:<z:chebi fb="0" ids="15379">O(2)</z:chebi> oxidoreductase activity was lowest in type 2 diabetic subjects and highest in the lean volunteers (lean 0.95 +/- 0.17, <z:mp ids='MP_0001261'>obese</z:mp> 0.76 +/- 0.30, type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> 0.56 +/- 0.14 units/mU <z:chebi fb="2" ids="16919">creatine</z:chebi> kinase; P &lt; 0.005) </plain></SENT>
<SENT sid="7" pm="."><plain>Also, <z:chebi fb="2" ids="50744">citrate</z:chebi> synthase activity was reduced in type 2 diabetic patients (lean 3.10 +/- 0.74, <z:mp ids='MP_0001261'>obese</z:mp> 3.24 +/- 0.82, type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> 2.48 +/- 0.47 units/mU <z:chebi fb="2" ids="16919">creatine</z:chebi> kinase; P &lt; 0.005) </plain></SENT>
<SENT sid="8" pm="."><plain>As measured by electron microscopy, skeletal muscle mitochondria were smaller in type 2 diabetic and <z:mp ids='MP_0001261'>obese</z:mp> subjects than in muscle from lean volunteers (P &lt; 0.01) </plain></SENT>
<SENT sid="9" pm="."><plain>We conclude that there is an impaired bioenergetic capacity of skeletal muscle mitochondria in type 2 <z:mp ids='MP_0002055'>diabetes</z:mp>, with some impairment also present in <z:hpo ids='HP_0001513'>obesity</z:hpo> </plain></SENT>
</text></document>